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BACKGROUND
The age at which allergenic foods should be introduced into the diet of breast-fed 
infants is uncertain. We evaluated whether the early introduction of allergenic 
foods in the diet of breast-fed infants would protect against the development of 
food allergy.
METHODS
We recruited, from the general population, 1303 exclusively breast-fed infants who 
were 3 months of age and randomly assigned them to the early introduction of six 
allergenic foods (peanut, cooked egg, cow’s milk, sesame, whitefish, and wheat; 
early-introduction group) or to the current practice recommended in the United 
Kingdom of exclusive breast-feeding to approximately 6 months of age (standard-
introduction group). The primary outcome was food allergy to one or more of the 
six foods between 1 year and 3 years of age.
RESULTS
In the intention-to-treat analysis, food allergy to one or more of the six interven-
tion foods developed in 7.1% of the participants in the standard-introduction 
group (42 of 595 participants) and in 5.6% of those in the early-introduction group 
(32 of 567) (P = 0.32). In the per-protocol analysis, the prevalence of any food al-
lergy was significantly lower in the early-introduction group than in the standard-
introduction group (2.4% vs. 7.3%, P = 0.01), as was the prevalence of peanut al-
lergy (0% vs. 2.5%, P = 0.003) and egg allergy (1.4% vs. 5.5%, P = 0.009); there were 
no significant effects with respect to milk, sesame, fish, or wheat. The consump-
tion of 2 g per week of peanut or egg-white protein was associated with a sig-
nificantly lower prevalence of these respective allergies than was less consump-
tion. The early introduction of all six foods was not easily achieved but was safe.
CONCLUSIONS
The trial did not show the efficacy of early introduction of allergenic foods in an 
intention-to-treat analysis. Further analysis raised the question of whether the 
prevention of food allergy by means of early introduction of multiple allergenic 
foods was dose-dependent. (Funded by the Food Standards Agency and others; 
EAT Current Controlled Trials number, ISRCTN14254740.)
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The World Health Organization recommends exclusive breast-feeding of infants for their first 6 months of life.1 
Two national guidelines that had previously rec-
ommended the delayed introduction of aller-
genic foods have been withdrawn (see the Intro-
duction section in the Supplementary Appendix, 
available with the full text of this article at 
NEJM.org). In the 2010 United Kingdom Infant 
Feeding Survey, 45% of the mothers of infants 8 
to 10 months of age reported avoiding giving 
their infant a particular food: 48% avoided nuts, 
14% eggs, 10% dairy, and 6% fish.2 Fear of allergy 
was the most common reason for avoiding foods, 
followed by a belief that the baby was too young.
Observational studies suggest that the early 
introduction of peanut,3 egg,4 or cow’s milk5 may 
prevent the development of allergy to these foods. 
The randomized, controlled Learning Early about 
Peanut Allergy (LEAP) trial showed that the early 
consumption of peanut in high-risk infants with 
severe eczema, egg allergy, or both reduced the 
development of peanut allergy by 80% by 5 years 
of age.6 The Persistence of Oral Tolerance to 
Peanut (LEAP-On) study has now shown that 
the absence of reactivity is maintained in these 
infants.7 However, the LEAP trial did not inves-
tigate the efficacy of introduction of other al-
lergenic foods, nor did it examine whether this 
approach could prevent peanut allergy in chil-
dren in the general population. The Enquiring 
about Tolerance (EAT) trial was therefore con-
ceived to determine whether the early introduc-
tion of common dietary allergens (peanut, cooked 
hen’s egg, cow’s milk, sesame, whitefish, and 
wheat) from 3 months of age in exclusively 
breast-fed infants in the general population 
would prevent food allergies than those in in-
fants who were exclusively breast-fed for ap-
proximately 6 months.
Me thods
Trial Design
This randomized, controlled trial was conducted 
at a single site in the United Kingdom. Ethics 
approval was provided by the St. Thomas’ Hos-
pital research ethics committee. Written informed 
consent was obtained from parents or guard-
ians, and safety data were reviewed by an inde-
pendent data and safety monitoring committee. 
The trial protocol is available at NEJM.org.
Trial Procedures
Enrollment took place from November 2, 2009, 
to July 30, 2012. Details of the trial procedures 
have been published previously.8 Singleton in-
fants who were 3 months of age and exclusively 
breast-fed were recruited from the general popu-
lation in England and Wales. Participants were 
randomly assigned by an independent online 
service to the standard-introduction group or 
the early-introduction group (Fig. S1 in the Sup-
plementary Appendix). Participants in the stan-
dard-introduction group were to be exclusively 
breast-fed to approximately 6 months of age. Af-
ter 6 months of age, the consumption of aller-
genic foods was allowed according to parental 
discretion. After skin-prick testing in duplicate 
at baseline, participants in the early-introduction 
group had six allergenic foods introduced: cow’s 
milk (yogurt) first, followed (in random order) 
by peanut, cooked (boiled) hen’s egg, sesame, 
and whitefish; wheat was introduced last. The 
infants in the standard-introduction group did 
not undergo skin-prick testing at baseline be-
cause the results could have influenced the tim-
ing of the introduction of allergenic foods.
Infants in the early-introduction group who 
had a wheal of any size on skin-prick testing at 
baseline underwent an open-label incremental 
food challenge totaling 2 g of protein of that 
food. Families of infants in the early-introduction 
group who had negative results on skin-prick 
testing or who had positive results on skin-prick 
testing but negative results on the food challenge 
were asked to continue feeding their infants 2 g 
of the allergen protein twice weekly. Families of 
infants who had a positive result on the food 
challenge at baseline were instructed to avoid 
giving the infants that food but to continue 
feeding the infants the other foods.
All the families completed an online ques-
tionnaire each month to 1 year of age, and then 
every 3 months until the child reached 3 years of 
age. This questionnaire recorded the frequency of 
consumption of allergenic foods in the two groups. 
In addition, the parents of the participants in the 
early-introduction group kept a weekly diary to 
record the quantity of the six foods consumed.8
Peanut-protein levels were measured in dust 
collected from the participant’s bed at 3 months 
of age (before the consumption of allergenic foods 
commenced in the early-introduction group) and at 
12 months of age as an independent measure of 
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adherence to the dietary intervention.9,10 Partici-
pants had scheduled assessments at 1 year of age 
and 3 years of age and had unscheduled clinic 
visits for the investigation of parent-reported 
symptoms that were suggestive of food allergy. 
Additional details are provided in the Methods 
section and Tables S1, S2, and S3 and Figs. S2, 
S3, and S4 in the Supplementary Appendix.
Outcomes
The primary outcome was challenge-proven food 
allergy to one or more of the six early-introduc-
tion foods between 1 year and 3 years of age. In 
two exceptional circumstances, reactions to foods 
that occurred before 1 year of age were also in-
cluded in the primary outcome. Categories of evi-
dence for food allergy are presented in the 
Methods section in the Supplementary Appen-
dix. Secondary outcomes were allergy to indi-
vidual foods and positive results on skin-prick 
testing for individual foods.
Statistical Analysis
The statistical analysis followed a prespecified 
analysis plan. Post hoc analyses included a 
dominance analysis of factors contributing to 
having a positive result with respect to the pri-
mary outcome and to not adhering to the proto-
col in the two study groups. Dominance analysis 
discerns the relative importance of independent 
variables in an estimation model on the basis of 
the contribution of each variable to the fit statis-
tics of the overall model (all post hoc analyses 
are listed in the Methods section in the Supple-
mentary Appendix).
The intention-to-treat analysis for the prima-
ry outcome included all the participants who 
had data that could be evaluated. The analysis, 
which compared the proportion of participants 
in the two groups who had food allergy to one 
or more of the early-introduction foods, was per-
formed with a chi-square test. For secondary 
analyses, comparisons were made with the chi-
square test or Fisher’s exact test, as appropriate. 
The trial had 80% power at the 5% significance 
level to detect a halving of the prevalence of food 
allergy, from 8% in the standard-introduction 
group to 4% in the early-introduction group.8
The per-protocol population included all par-
ticipants who adhered adequately to the assigned 
regimen, which was defined as follows. In each 
group, breast-feeding was continued to at least 
5 months of age. In the standard-introduction 
group, there was no consumption of peanut, egg, 
sesame, fish, or wheat before 5 months of age 
and consumption of less than 300 ml per day of 
formula milk between 3 and 6 months of age. In 
the early-introduction group, there was consump-
tion of at least five of the early-introduction foods, 
for at least 5 weeks between 3 and 6 months of 
age, of at least 75% of the recommended dose 
(i.e., 3 g per week of allergenic protein). The 
per-protocol population for food-specific allergy 
used the same consumption criterion — con-
sumption for at least 5 weeks between 3 and 
6 months of age of at least 75% of the recom-
mended dose of that food (i.e., 3 g per week of 
allergenic protein). The data set will be made 
publicly available by August 2017.
R esult s
Participant Population
The median age of the participants at enroll-
ment was 3.4 months. The two groups were 
balanced, except for a significantly higher rate 
of birth by cesarean section in the early-intro-
duction group than in the standard-introduction 
group (Table S4 in the Supplementary Appendix). 
A total of 91.3% of the participants attended the 
final clinic visit, 90.0% of whom attended within 
the visit window (by 4 years of age). A total of 
94.0% of the participants’ families completed the 
3-year questionnaire.
Food Allergy
A food allergy developed in 74 participants. In 70 
of these participants (39 in the standard-introduc-
tion group and 31 in the early-introduction group), 
diagnoses were made on the basis of double-
blind, placebo-controlled food challenges (pri-
mary-outcome categories 1A and 1B), and in 4 
(3 in the standard-introduction group and 1 in 
early-introduction group), diagnoses were made 
on the basis of an allergic reaction that resulted 
in a wheal size of 5 mm or more in diameter on 
skin-prick testing (primary-outcome category 3). 
A diagnosis of any food allergy was significantly 
associated with the presence of eczema at en-
rollment, nonwhite race, and having siblings. In 
the post hoc dominance analysis, these three 
factors accounted for 92.6% of the variation in 
the fit statistic of the overall logistic model 
(Table S5 in the Supplementary Appendix).
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Food Consumption and Allergy  
in the Intention-to-Treat Analyses
For the primary outcome, 595 of 651 enrolled 
participants (91.4%) in the standard-introduction 
group and 567 of 652 (87.0%) in the early-intro-
duction group were included in the intention-to-
treat analysis (Fig. S1 in the Supplementary Ap-
pendix). The rate of the primary outcome was 
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nonsignificantly lower in the early-introduction 
group than in the standard-introduction group 
(5.6% [32 of 567 participants] and 7.1% [42 of 
595], respectively), which represented a relative 
risk of 0.80 (95% confidence interval [CI], 0.51 
to 1.25; P = 0.32), with the point estimate repre-
senting a 20% lower prevalence in the early-intro-
duction group (Fig. 1, and Table S6 in the Sup-
plementary Appendix). The prevalence of allergy 
to more than one food was nonsignificantly 
lower in the early-introduction group than in the 
standard-introduction group (P = 0.17) (Table S7 
in the Supplementary Appendix).
Peanut allergy occurred in 1.2% of the par-
ticipants in the early-introduction group and in 
2.5% of those in the standard-introduction 
group, representing a nonsignificant 51% lower 
relative risk in the early-introduction group 
(P = 0.11). Egg allergy occurred in 3.7% of the 
participants in the early-introduction group 
and in 5.4% of those in the standard-introduc-
tion group, representing a nonsignificant 31% 
lower relative risk in the early-introduction group 
(P = 0.17) (Fig. 1).
For other early-introduction foods, the preva-
lence of food allergy was 0.7% or less in each 
group (Fig. S5 in the Supplementary Appendix). 
Non–IgE-mediated allergy-type symptoms are dis-
cussed in Tables S8 and S9 and the Results section 
in the Supplementary Appendix.
Food Consumption and Allergy  
in the Per-Protocol Analysis
In the per-protocol analysis, the rate of the pri-
mary outcome was significantly lower in the 
early-introduction group than in the standard-
introduction group (2.4% [5 of 208 participants] 
vs. 7.3% [38 of 524]). The relative risk in the early-
introduction group was 0.33 (95% CI, 0.13 to 0.83; 
P = 0.01), representing a prevalence that was 67% 
lower than that in the standard-introduction group 
(Fig. 1).
With regard to food-specific per-protocol con-
sumption, the protective effects with respect to 
egg and peanut were larger in the early-introduc-
tion group than in the standard-introduction 
group. In the per-protocol analysis of peanut 
consumption, there were no cases of peanut al-
lergy among the 310 participants in the early-
introduction group, as compared with 13 cases 
among 525 participants (2.5%) in the standard-
introduction group (P = 0.003) (Fig. 1). The prev-
alence of egg allergy among participants who 
adhered to the protocol with respect to egg con-
sumption was 1.4% in the early-introduction 
group versus 5.5% in the standard-introduction 
group, representing a 75% lower relative risk 
(P = 0.009) (Fig. 1). The rates of food allergy in 
the per-protocol analysis were lower, but not 
significantly so, in the early-introduction group 
than in the standard-introduction group for 
milk (P = 0.63) and sesame (P = 0.56). There were 
no cases of wheat allergy in either group in the 
per-protocol analysis. The rate of fish allergy 
was nonsignificantly higher in the early-intro-
duction group than in the standard-introduction 
group (P = 1.00) (Fig. S5 in the Supplementary 
Appendix).
Although adjustment for multiple testing was 
not part of the statistical analysis plan, if these 
six component food tests were adjusted for mul-
tiple testing with the use of a Bonferroni correc-
tion, the critical value for statistical significance 
would be 0.0085 (i.e., 1 − 0.951/6). Under this con-
Figure 1 (facing page). Primary Outcome of Allergy  
to One or More Foods and Secondary Outcomes  
of Allergy to Peanut and to Egg.
The prevalence of IgE-mediated food allergy is shown 
with respect to one or more of the six early-interven-
tion foods (peanut, cooked egg, cow’s milk, sesame, 
whitefish, and wheat; Panel A), to peanut (Panel B), 
and to egg (Panel C). The results regarding IgE-medi-
ated food allergy to the other early-introduction foods 
are shown in Figure S5 in the Supplementary Appen-
dix. The first column shows the intention-to-treat 
analysis, the second column the per-protocol analysis, 
and the third column an adjusted per-protocol analy-
sis. The intention-to-treat analysis included all the par-
ticipants who had data that could be evaluated; the 
per-protocol population included all participants who 
adhered adequately to the assigned regimen. The ad-
justed per-protocol analysis was a conservative per-
protocol analysis that adjusted the prevalence of food 
allergy in the standard-introduction group by subtract-
ing the number of participants in the early-introduc-
tion group who had a positive result on the challenge 
at enrollment and who completed the trial with a con-
firmed food allergy from both the numerator (the 
number of participants with allergy in the standard- 
introduction group) and the denominator (the number 
of participants in the standard-introduction group 
who adhered to the protocol). P values are based on 
chi-square analyses or Fisher’s exact test, as appropri-
ate. The relative risks with 95% confidence intervals 
are shown in Table S6 (intention-to-treat analysis) and 
Table S10A (per-protocol analysis) in the Supplemen-
tary Appendix.
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straint, in the per-protocol analysis the effect on 
peanut allergy would remain significant, and 
the results for egg would remain borderline sig-
nificant (see the Discussion section in the Sup-
plementary Appendix).
Protective effects with respect to the primary 
outcome and with respect to peanut allergy and 
egg allergy remained significant in the conser-
vative adjusted per-protocol analysis. This analysis 
was not adjusted for multiple comparisons (Fig. 1, 
and the Results section in the Supplementary Ap-
pendix).
Participants in the two trial groups who did 
not adhere to the protocol or whose adherence 
could not be evaluated had rates of allergy that 
were similar to the rate among the participants 
in the standard-introduction group who adhered 
to the protocol. Statistical comparisons between 
the participants in the standard-introduction group 
who adhered to the protocol and the participants 
in the early-introduction group who did not ad-
here to the protocol or whose adherence could not 
be evaluated were all nonsignificant (Table S10B 
in the Supplementary Appendix).
Results of Skin-Prick Testing
A similar pattern was seen for the results of skin-
prick testing (Fig. 2). In the intention-to-treat 
analyses, the risk of a positive skin-prick test to 
any food was 22% lower in the early-introduc-
tion group than in the standard-introduction 
group at 12 months of age (P = 0.07) and 12% 
lower at 36 months of age (P = 0.47); both differ-
ences were nonsignificant. Positive skin-prick tests 
to wheat occurred significantly less frequently in 
the early-introduction group than in the stan-
dard-introduction group at 12 months (1.3% vs. 
3.2%, P = 0.03) and at 36 months of age (1.4% vs. 
3.2%, P = 0.04). The prevalence of positive skin-
prick tests at 12 months and 36 months of age 
was nonsignificantly lower in the early-introduc-
tion group than in the standard-introduction 
group for every other food, with the exception of 
fish at 12 months of age, which had a higher 
prevalence in the early-introduction group (Fig. 2, 
and Fig. S6 and Table S11 in the Supplementary 
Appendix).
In the per-protocol analyses, the early-intro-
duction group had a significant 42% lower rate 
of positive skin-prick tests to any food than the 
standard-introduction group at 12 months of age 
(P = 0.01) and a significant 67% lower rate at 36 
months of age (P = 0.002). On food-specific test-
ing, the relative risk of a positive result on skin-
prick testing at 12 months of age was consistently 
lower, by approximately 50%, in the early-intro-
duction group than in the standard-introduction 
group for every food with the exception of fish; 
the difference was significant with respect to egg 
(P = 0.009) and peanut (P = 0.04). At 36 months of 
age, the effect was greater; the relative risk of a 
positive result on skin-prick testing was 67% 
lower in the early-introduction group than in the 
standard-introduction group with respect to 
peanut (P = 0.007), 48% lower with respect to 
egg (P = 0.10), 88% lower with respect to milk 
(P = 0.02), 100% lower with respect to both sesa-
me (P = 0.04) and fish (P = 0.17), and 69% lower 
with respect to wheat (P = 0.12). The rate of a 
positive skin-prick test to raw egg white was also 
lower in the early-introduction group than in the 
standard-introduction group at 36 months of 
age; the 49% lower relative risk (P = 0.07) was 
similar to that observed with commercial egg 
extract (Fig. 2, and Table S11 in the Supplemen-
tary Appendix).
Adherence to the Protocol
A total of 92.9% of the participants in the stan-
dard-introduction group whose primary-outcome 
status could be determined (524 of 564 partici-
pants) adhered to the protocol (Fig. S1 in the 
Supplementary Appendix). In the dominance 
analysis, shorter duration of maternal education 
and maternal smoking accounted for the majority 
of the variation in the fit statistic of the overall 
model (Tables S12 and S13 in the Supplementary 
Appendix). A total of 85.6% of the participants in 
the standard-introduction group consumed no 
cow’s milk formula before 6 months of age.
A total of 42.8% of the participants in the 
early-introduction group whose primary-out-
come status could be determined (208 of 486 
participants) adhered to the protocol (represent-
ing 31.9% of the total number of participants 
enrolled in the early-introduction group) (Fig. S1 
in the Supplementary Appendix). Four factors 
accounted for 78% of the nonadherence in the 
dominance analysis: nonwhite race (odds ratio, 
2.21; 95% CI, 1.18 to 4.14), parentally perceived 
symptoms in the child related to any of the 
early-introduction foods (odds ratio, 1.70; 95% 
CI, 1.02 to 2.86), reduced maternal quality of life 
(psychological domain) (odds ratio, 0.69; 95% 
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CI, 0.47 to 1.00), and the presence of eczema in 
the child at enrollment (odds ratio, 1.38; 95% CI, 
0.87 to 2.19) (Tables S12 and S14 in the Supple-
mentary Appendix).
The rate of adherence to the protocol with 
respect to individual foods in the early-introduc-
tion group varied. The rates were as follows: 
43.1% for egg (215 of 499 participants), 50.7% 
for sesame (266 of 505), 60.0% for fish (297 of 
495), 61.9% for peanut (310 of 501), and 85.2% 
for milk (415 of 487).
The levels of peanut protein in bed dust were 
similar at baseline in the early-introduction 
group and the standard-introduction group (me-
dian, 7.6 μg of peanut protein per gram of dust 
and 9.7 μg per gram, respectively). However, by 
1 year of age, the levels were significantly higher 
in the early-introduction group than in the 
standard-introduction group (387.9 μg of peanut 
protein per gram of dust vs. 77.0 μg per gram, 
P<0.001). At 1 year of age, participants in the 
early-introduction group who adhered to the 
protocol had higher levels of peanut protein in 
bed dust than did those in the same trial group 
who did not adhere to the protocol (P = 0.04) 
(Fig. S7 in the Supplementary Appendix). Fur-
ther details on adherence to the protocol are 
provided in the Results section in the Supple-
mentary Appendix.
 Dose–Response Analysis
Variations in the number of foods consumed, 
the weekly dose of each food consumed, and the 
number of weeks during which this dose was 
consumed resulted in a rate of adherence in the 
early-introduction group that ranged from 6% to 
81%. The prevalence of food allergy overall and 
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Figure 2. Secondary Outcome of Results on Skin-Prick 
Testing.
The prevalence of a positive skin-prick test (wheal of 
any size) is shown for one or more of the six early-
intervention foods (Panel A), peanut (Panel B), egg 
(Panel C), and raw egg white (Panel D; this test was 
performed only at the 36-month visit). Results of skin-
prick testing for the other early-introduction foods are 
shown in Figure S6 in the Supplementary Appendix. 
The first column shows the intention-to-treat analysis, 
and the second column the per-protocol analysis. 
P values are based on chi-square analyses. The group-
specific denominators and relative risks with 95% 
confidence intervals are shown in Table S11 in the 
Supplementary Appendix.
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the prevalence of allergy to specific foods were 
reduced in concert with increases in any of these 
variables. At a consumption level of 2 g or more 
per week of allergenic protein for 4 or more 
weeks, peanut was consumed by 85.3% of the 
participants in the early-introduction group for 
whom adherence with peanut consumption 
could be determined (419 of 491 participants) 
and egg by 75.5% (370 of 490). The correspond-
ing rates of allergy were 0.2% for peanut and 
1.9% for egg. Details are provided in Tables 
S15A, S15B, and S16 in the Supplementary Ap-
pendix.
The mean weekly consumption of egg and 
peanut protein between enrollment and 6 months 
of age was calculated and divided into quartiles. 
The prevalence of allergy to peanut and egg and 
the prevalence of positive responses on skin-
prick testing to peanut, egg, and raw egg white 
diminished with increasing quartile levels of 
consumption (Fig. S8 in the Supplementary Ap-
pendix). The mean weekly consumption data were 
used to generate predictive probability plots that 
were based on logistic modeling; analysis showed 
that higher consumption was associated with a 
lower prevalence of allergy and sensitization to 
that food (Fig. 3). The mean weekly consumption 
of 2 g of peanut protein and 4 g of egg protein 
(equivalent to 2 g of egg-white protein) was as-
sociated with the prevention of these two respec-
tive food allergies. The consumption of cooked 
egg was equally effective in inhibiting reactivity 
to raw egg-white protein and egg extract on skin-
prick testing at 3 years of age.
Safety
No deaths occurred in the trial. There were three 
life-threatening events, all of which occurred in 
the standard-introduction group; none were re-
lated to allergic disease (heart-valve damage, pro-
longed febrile convulsion, and extensive burns). 
There were no significant between-group differ-
ences in the rates of hospitalization. There were 
no cases of anaphylaxis with the introduction of 
foods at home in the early-introduction group. 
The use of the epinephrine autoinjector is dis-
cussed in the Results section in the Supplemen-
tary Appendix.
The rate of visits to the emergency depart-
ment was similar in the two groups. The early-
introduction regimen did not affect the growth 
of the participants or the duration of breast-
feeding.8 Details on safety outcomes are pro-
vided in Tables S17 through S28 and Figures S9 
through S19 in the Supplementary Appendix.
Results According to Skin-Prick Testing  
and Allergy Status at Baseline
At enrollment, 33 of the 652 participants in the 
early-introduction group (5.1%) had a positive 
skin-prick test to an early-introduction food. All 
33 participants were invited to undergo food chal-
lenges to the relevant foods: 7 participants had 
positive results (to one or more foods), 22 had 
negative results (to one or more foods), and 4 did 
not return for the challenges. Of the 7 partici-
pants who had a positive result on a challenge at 
baseline, 5 subsequently had a positive result 
with respect to the primary outcome, 1 had a 
negative result, and 1 withdrew from the trial. 
Of the 22 participants who had negative results 
on the challenge at baseline, 1 subsequently had 
a positive result with respect to the primary out-
come, 3 could not be evaluated, and 18 had a 
negative result. Details are provided in Table 
S29A in the Supplementary Appendix.
All the reactions in the seven participants 
who had positive results on challenges at base-
line were mild (Table S30 in the Supplementary 
Appendix). There were 10 positive challenges 
among these seven participants; 6 reactions re-
quired no treatment, and 4 were treated with 
antihistamines. There were no cases of anaphy-
laxis during the challenges, and no intramuscu-
lar epinephrine was administered.
Discussion
This trial did not show efficacy of early intro-
duction of allergenic foods versus standard in-
troduction in an intention-to-treat analysis; there 
was a nonsignificant 20% lower relative risk of 
food allergy in the early-introduction group than 
in the standard-introduction group. In the per-
protocol analysis, there was a significant 67% 
lower relative risk of food allergy overall in the 
early-introduction group. Unexpectedly, in the 
per-protocol analysis, significantly lower relative 
risks of peanut allergy and egg allergy were ob-
served in the early-introduction group than in 
the standard-introduction group (P = 0.003 and 
P = 0.009, respectively). The rates of other food 
allergies were too low to show any effects. Never-
theless, at 36 months of age, the average relative 
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risk of a positive skin-prick test to the six indi-
vidual foods was 79% lower in the early-introduc-
tion group than in the standard-introduction 
group; findings were significant for peanut 
(P = 0.007), milk (P = 0.02), and sesame (P = 0.04). 
The efficacy of the intervention was related to 
the duration of consumption of the specific 
food and the quantity of food consumed be-
tween 3 months and 6 months of age.
We found that the early introduction of al-
lergenic foods was safe, with no cases of ana-
phylaxis during the initial introduction regimen 
and no adverse effects on breast-feeding or 
growth.8 Partial adherence among participants in 
the early-introduction group was not associated 
with any increase in the prevalence of allergy. 
Seven participants in the early-introduction group 
had positive results on food challenges at base-
line, and hence complete adherence to the early-
introduction protocol in this trial would not 
have prevented all cases of food allergy from 
occurring.
The per-protocol consumption of cooked egg 
resulted in a lower rate of a positive skin-prick 
test to raw egg white (by 49%) and to commer-
cial egg extract, which suggests that the possible 
protective effect is not confined to the form in 
which the individual food is consumed. The Hen’s 
Egg Allergy Prevention (HEAP) study, which en-
rolled patients from the general population,11 and 
the Solids Timing for Allergy Research (STAR) 
study, which enrolled high-risk patients,12 intro-
duced raw-egg powder but showed significant side 
effects. Our data suggest that the introduction 
of cooked egg is a safe strategy and may be ef-
fective for prevention.
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Figure 3. Dose–Response Analysis of the Relationship 
between Mean Weekly Dose of Peanut or Egg Protein 
Consumed and Allergy or Positive Result on Skin-Prick 
Testing to Peanut, Egg, and Raw Egg White.
Shown are the predictive probability plots that were 
generated from statistical models of the prevalence of 
peanut allergy and egg allergy (Panel A) and of a posi-
tive result on skin-prick testing to peanut and egg at 
12 months (Panel B) and to peanut, egg, and raw egg 
white at 36 months (Panel C), according to the mean 
weekly consumption of peanut and egg protein be-
tween enrollment and 6 months of age. The prevalence 
of both food allergy and positive skin-prick test dimin-
ishes with increasing levels of mean weekly consump-
tion. Insets show the same data on an enlarged y axis. 
Plots of the raw data and the probability plots are 
shown in Figure S8 in the Supplementary Appendix.
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The rates of food allergy were higher among 
nonwhite participants than among whites and 
higher among participants with eczema at en-
rollment than among those without eczema — 
findings that are consistent with those in the 
literature; however, adherence to the trial proto-
col was significantly lower among participants 
in the early-introduction group who were non-
white and was lower (but not significantly) 
among those who had eczema than among the 
rest of the standard-introduction group.13-15 Ad-
herence was also lower in cases in which parents 
perceived symptoms in their child with the early 
introduction of the foods and in cases in which 
mothers had a lower psychological quality of life 
at enrollment. These results raise the question of 
whether targeted clinical and dietetic support to 
these families at the earliest stages of food in-
troduction could possibly augment adherence, 
and this concept requires further consideration 
if early introduction is to be considered as a 
policy to reduce the prevalence of food allergies.
The strengths of our trial included a high 
retention rate, the fact that nearly all cases of 
allergy were confirmed in a double-blind, place-
bo-controlled challenge, the enrollment of an 
unselected population of exclusively breast-fed 
infants, and the fact that all the children with a 
positive skin-prick test were invited to undergo a 
food challenge. The main weakness of the study 
was the low rate of per-protocol adherence in the 
early-introduction group, as discussed below.
There are a number of possible explanations 
for the finding of efficacy at the per-protocol 
level as opposed to the intention-to-treat level. 
The first is that the early introduction of aller-
genic foods prevented the development of food 
allergy. This explanation has some plausibility, 
given the food-specific findings and an apparent 
dose–response relationship for protection against 
peanut allergy and egg allergy. Reverse causality 
would provide a second explanation, reflecting 
the possibility that infants with nascent food 
allergy were less likely to successfully consume 
the foods because of aversive feeding behavior, 
which is the first sign of clinical food allergy. If 
this were the case, we would anticipate an excess 
of food allergy among the participants in the early-
introduction group who did not adhere to the 
protocol, but there was no evidence of this. Fur-
thermore, the 3-month-old infants who were most 
at risk for nascent food allergy (positive skin-
prick test at enrollment but negative result on 
the food challenge at baseline) did not have lower 
rates of adherence to the early-introduction pro-
tocol than those in this group who had a negative 
skin-prick test.
A third potential explanation is that of bias 
leading to a higher prevalence of atopy and food 
allergy among children outside the per-protocol 
analysis. This is an important consideration, 
given that only 31.9% of all the enrolled partici-
pants in the early-introduction group (208 of 
652 participants) adhered to the protocol and 
had a primary outcome that could be evaluated, 
as compared with 80.5% in the standard-intro-
duction group (524 of 651). Differential attrition 
between the two groups potentially introduces 
bias. An analysis for evidence of bias in the par-
ticipants who were not in the group that adhered 
to the protocol does not provide an explanation 
for the apparent efficacy in the per-protocol 
analyses (Tables S12 and S31 in the Supplemen-
tary Appendix).
Finally, we eliminated the possibility that our 
findings were the result of an artifact of study 
design — the selective removal of participants 
who had food allergy at baseline exclusively from 
the early-introduction group. When the partici-
pants were 3 months of age, we evaluated food 
allergy only in the early-introduction group. 
Participants with confirmed food allergy at this 
point were unable to adhere to the protocol, 
which thus artificially lowered the rate of food 
allergy in this group. We therefore undertook an 
adjusted per-protocol analysis in which we sub-
tracted the same number of participants with 
food allergy from the standard-introduction group. 
The results remained significant after the adjust-
ment (Fig. 1). Nevertheless, we cannot be certain 
whether unmeasured sources of bias still exist.
Modeling determined that 2 g or more of 
peanut or egg-white protein per week may pre-
vent these respective allergies. This level of con-
sumption matches the median level of consump-
tion observed in Israeli infants 8 to 14 months 
of age (7.1 g per month), who have a rate of 
peanut allergy that is 10 times lower than that 
among Jewish children in the United Kingdom, 
who consume very little peanut (0.17% vs. 1.85%).3 
In the EAT trial, this level of peanut consump-
tion for at least 4 weeks also resulted in a rate of 
peanut allergy that was 10 times lower than that 
among the participants in the standard-intro-
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duction group (2.5% vs. 0.2%) — a finding that 
mirrors that of Du Toit et al.3 The results of our 
trial are complementary to those of the LEAP 
trial. Only 9 of the 1303 participants in our trial 
would have been considered to be at sufficiently 
high risk to enroll in the LEAP trial. It should be 
noted that 76% of the participants in the stan-
dard-introduction group did not have eczema at 
3 months of age, and yet they accounted for 38% 
of the participants in the standard-introduction 
group with food allergy to one or more of the 
foods tested (Table S32 in the Supplementary Ap-
pendix; additional information regarding many 
of the findings discussed in this section is avail-
able in the Discussion section of the Supplemen-
tary Appendix).
This trial failed to show the efficacy of early 
introduction of allergenic foods as compared 
with standard introduction of those foods in an 
intention-to-treat analysis. Further analysis sug-
gests that the possibility of preventing food al-
lergy by means of the early introduction of mul-
tiple allergenic foods in normal breast-fed infants 
may depend on adherence and dose.
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